Position history for BlackRock, Inc.'s holdings in CORVUS PHARMACEUTICALS INC
BlackRock, Inc. holds 5.1M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $38.9M as of 2025-Q4. The position was increased (++7.3% shares). CRVS represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$38.9M
Current Shares
5.1M
Total Value Change
+$33.2M
Total Shares Change
+4M
Other major holders of CRVS: Point72 Asset Management, L.P., VANGUARD GROUP INC, MORGAN STANLEY
Increased |
| 5.1M |
+7.3% |
| $38.9M |
| 0.0% |
| $7.49 |
31 |
| 2025-Q3 | Increased | 4.7M | +11.1% | $34.7M | 0.0% | $7.28 | 32 |
| 2025-Q2 | Increased | 4.2M | +301.0% | $17M | 0.0% | $3.89 | 46 |
| 2025-Q1 | Decreased | 1.1M | -1.5% | $3.4M | 0.0% | $3.38 | 0 |
| 2024-Q4 | New | 1.1M | - | $5.7M | 0.0% | $5.25 | 37 |